23 results
8-K
KPRX
Kiora Pharmaceuticals Inc
21 Sep 23
Kiora Pharmaceuticals Appoints Praveen Tyle, PhD, as New Chairman; Succeeds Paul Chaney Who is Retiring After Serving 17 Years
7:00am
disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
In connection with Mr. Chaney’s retirement
8-K
EX-3.1
KPRX
Kiora Pharmaceuticals Inc
4 Aug 22
Amendments to Articles of Incorporation or Bylaws
4:36pm
elected and qualified, or until such director’s prior death, resignation, retirement, disqualification or other removal. The Board of Directors … in the Board of Directors resulting from death, resignation, retirement, disqualification, removal from office or other cause shall, unless otherwise provided
8-K
EX-10.1
KPRX
Kiora Pharmaceuticals Inc
1 Feb 22
Kiora Pharmaceuticals Appoints Erin Parsons to its Board of Directors; Stephen From to Retire from Board
6:45am
and Medical Leave Act of 1993, the Employee Retirement Income Security Act of 1974, the Age Discrimination in Employment Act, the Older Workers … to: (i) your entitlement under ERISA to vested retirement or pension benefits; (ii) enforcement of the terms of this Agreement; (iii) any claims
8-K
EX-3.2
mt1ggstr
8 Nov 21
EyeGate is Now Kiora Pharmaceuticals; Provides Update on Company’s
7:32am
8-K
EX-10.1
g15s443fkko kw
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
8-K
EX-2.1
0q4ily
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
8-K
EX-10.1
uh6s36pryt8q2yx439
26 Jul 21
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D., as President and Chief Executive Officer
4:18pm
8-K
EX-2.1
4xm35ardvurpq7a
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
8-K
EX-10.1
qm57rz4a
24 Mar 20
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
edcph
3 Dec 19
Departure of Directors or Certain Officers
6:55am
8-K
EX-10.1
x1725r0wbla 04kcc8vw
10 Jul 15
EyeGate Signs Licensing Agreement with Valeant Pharmaceuticals for EGP-437 Combination Product in Uveitis
12:00am
8-K
EX-3.2
g6rbeydy dx9nhvpv02s
20 Feb 15
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.1
fw3yubs4h3api e5f7m
20 Feb 15
Amendments to Articles of Incorporation or Bylaws
12:00am